DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR ESTIMATION OF RIVAROXABAN USING HPLC-PDA IN HUMAN BLOOD PLASMA

Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 7

Abstract

Rivaroxaban is oral anti-coagulant drug, used in the treatment of various blood disorders. A sensitive and accurate liquid chromatographic methodfor the quantification of rivaroxaban in human plasma was successfully developed. Protein precipitation was used for sample preparation. Quantification of analyte was achieved on phenomenexluna C8 (5µm x 25cm x 4.6mm i.d.) column using methanol:water:dimethyl sulfoxide (50:45:5, v/v/v) as mobile phase at a flow rate of 1ml/min. Detection was achieved at 252nm over the linearity concentration range of 5-40µg/ml. Retention time was found 6.2 min. The LOD and LOQ were found to be 1.5 µg/ml and 4.5 µg/ml, respectively.The developed method was validate as per US FDA guidelines.

Authors and Affiliations

Satyendra Yadav

Keywords

Related Articles

HEPATOPROTECTIVE ACTIVITY OF THE EXTRACT OF CRATAEVA NURVALA BARK AGAINST CCL4 INDUCED HEPATOTOXICITY IN RATS

The present work is focused on investigation of hepatoprotective activity of bark of Crataeva nurvala. It’s hepatoprotective activity was studied in the form of its aqueous and ethanolic extract and its isolated compound...

PHARMACOGNOSTIAL EVALUATION AND PHYTOCHEMICAL SCREENING OF THEVETIA PERUVIANA

Flowers of Plant Thevetia peruviana (Pers.) K. Schum.were reported to possess good medicinal value in traditional system of medicine, the present investigation deals with Macroscopic, Microscopic and preliminary phytoche...

G.R.Y. Institute Pharmacy, Borawan, Khargone MP, India

Simple, accurate, precise, and sensitive ultraviolet spectrophotometric and reversed-phase high-performance liquid chromatographic (RP-HPLC) methods for simultaneous estimation of Atorvastatin (ATOR) and Pioglitazone (PI...

EFFECT OF NITROGEN SOURCE FOR THE BIOSYNTHESIS OF XYLANASE FROM ASPERGILLUS TAMARII

The main aim of the study is to enhance the biosynthesis of xylanse by incorporating nitrogen sources (both organic and inorganic). Recently, xylanases have expanded their use in many processing industries, such as pulp...

METHOD DEVELOPMENT AND ITS VALIDATION FOR QUANTITATIVE DETERMINATION OF BOSENTAN IN TABLET DOSAGE FORM BY RP-HPLC

Objectives of this research work were development and validation of HPLC methods of analysis for Bosentan in tablet dosage form from single components as per the current ICH & USP guidelines. HPLC methods also validated...

Download PDF file
  • EP ID EP300612
  • DOI -
  • Views 71
  • Downloads 0

How To Cite

Satyendra Yadav (2017). DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR ESTIMATION OF RIVAROXABAN USING HPLC-PDA IN HUMAN BLOOD PLASMA. Journal of Drug Delivery and Therapeutics, 7(7), 123-125. https://europub.co.uk/articles/-A-300612